3Burnier M;Roch-Ramel F Beunner HR.Renal eftects of angiotensin lireceptor blockade in normotnsive subiects[J],1996(06).
4Golderz Hi Dunlag MC;Sweet CS.Safetg and tolerahilig of losarren potassium. an angiotensin Ⅱ receptor antegemist, comparedwith HCTZ, atenolol, felodipine ER, and angiotensin conversing enzgme inhibitors for thetreatmet of systemic hgpertension[J],1995(12).
5Vachharajami N;Chang S Y;Shgu W C.Hbsolute bioavailabilitg of irbesartan,an angiotensin Ⅱ recetov antagonist,in man (abst),1995.
6The sixth report of the Jomt National Committee on Prevention and Ttreatment of High Blood Pressure[J],1997(02).
7MRC Working Party. British Medical Journal . 1992
8Lithel H et al. . 1992
9Andrew D et al. Journal of Clinical Endocrinology Metabolism The . 1996
6Swisloki A.Insulin resistance and hypertension[J].Am J Med Sci,1990,300:104.
7Ogihara T,Asano T,Ando K,et al.Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats[J].Diabetes,2001,50(3):573-83.
8Burnier M;Roch-Ramel F Beunner HR.Renal eftects of angiotensin lireceptor blockade in normotnsive subiects[J],1996(06).
9Golderz Hi Dunlag MC;Sweet CS.Safetg and tolerahilig of losarren potassium. an angiotensin Ⅱ receptor antegemist, comparedwith HCTZ, atenolol, felodipine ER, and angiotensin conversing enzgme inhibitors for thetreatmet of systemic hgpertension[J],1995(12).
10Vachharajami N;Chang S Y;Shgu W C.Hbsolute bioavailabilitg of irbesartan,an angiotensin Ⅱ recetov antagonist,in man (abst),1995.
